Kirn David Insider Profile

4 Followers
Kirn David, CEO, Director at 4D Molecular Therapeutics, holds 1.86M shares in 4D Molecular Therapeutics (Ticker: FDMT).
tipranks
Kirn David

Kirn David
4D Molecular Therapeutics (FDMT)
CEO, Director

Not Ranked
Kirn David has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$26M
100.00%
A breakdown of Kirn David's holdings

Insider Roles

4D Molecular Therapeutics
(FDMT)
CEO, Director
Roles that Kirn David holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kirn David

Kirn David's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
4D Molecular Therapeutics
May 04, 2023
CEO, Director
Uninformative Buy
$25.86M
Kirn David has not reported any informative transactions for FDMT, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 04, 2023
Uninformative Buy
$0.00
-
$0.00
Dec 19, 2022
Uninformative Sell
$2.02M
-
$23.22
Jan 23, 2023
Uninformative Sell
$392.36K
-
$20.09
Feb 23, 2023
Uninformative Sell
$709.77K
-
$20.60
May 04, 2023
Uninformative Sell
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Kirn David's performance on stock

Kirn David insider profile FAQ

What is the percentage of profitable transactions made by Kirn David?
The percentage of profitable transactions made by Kirn David is ―.
    What is the average return per transaction made by Kirn David?
    The average return per transaction made by Kirn David is ―.
      What stocks does Kirn David hold?
      Kirn David holds: FDMT stocks.
        What was Kirn David’s latest transaction?
        Kirn David latest transaction was an Uninformative Buy of ―.
          What was Kirn David's most profitable transaction?
          Kirn David’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kirn David's role in 4D Molecular Therapeutics?
            Kirn David's role in 4D Molecular Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.